Cargando…

Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP

Several splicing-modulating compounds, including Sudemycins and Spliceostatin A, display anti-tumor properties. Combining transcriptome, bioinformatic and mutagenesis analyses, we delineate sequence determinants of the differential sensitivity of 3′ splice sites to these drugs. Sequences 5′ from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigevani, Luisa, Gohr, André, Webb, Thomas, Irimia, Manuel, Valcárcel, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727392/
https://www.ncbi.nlm.nih.gov/pubmed/29235465
http://dx.doi.org/10.1038/s41467-017-02007-z

Ejemplares similares